Primary hepatocytes isolated from the liver are effective tools for the in vitro evaluation of metabolism, drug-drug interactions, hepatotoxicity, and transporter activity.

TriDixTM Bio plateable hepatocytes offer high viabilities (routinely greater than 80%), in vivo-like enzyme expression levels, and are characterized for phase I and phase II drug metabolizing enzyme activities. They are ideal for reproducible long-term and multi-site studies. Our plateable hepatocytes are also spheroid qualified for the generation of hepatic spheroids in your own lab. Each vial contains a minimum of five million viable cells, sufficient for up to sixteen 96-well plates of hepatic spheroids.

TDC-P1102-product-datasheet-hepatocytes.pdf